Literature DB >> 21948122

Exercise-associated collapse: an evidence-based review and primer for clinicians.

Chad A Asplund1, Francis G O'Connor, Timothy D Noakes.   

Abstract

Exercise-associated collapse (EAC) commonly occurs after the completion of endurance running events. EAC is a collapse in conscious athletes who are unable to stand or walk unaided as a result of light headedness, faintness and dizziness or syncope causing a collapse that occurs after completion of an exertional event. Although EAC is perhaps the most common aetiology confronted by the medical provider attending to collapsed athletes in a finish-line tent, providers must first maintain vigilance for other potential life-threatening aetiologies that cause collapse, such as cardiac arrest, exertional heat stroke or exercise-associated hyponatraemia. Previously, it has been believed that dehydration and hyperthermia were primary causes of EAC. On review of the evidence, EAC is now believed to be principally the result of transient postural hypotension caused by lower extremity pooling of blood once the athlete stops running and the resultant impairment of cardiac baroreflexes. Once life-threatening aetiologies are ruled out, treatment of EAC is symptomatic and involves oral hydration and a Trendelenburg position - total body cooling, intravenous hydration or advanced therapies is generally not needed.

Entities:  

Mesh:

Year:  2011        PMID: 21948122     DOI: 10.1136/bjsports-2011-090378

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  13 in total

Review 1.  Managing collapsed or seriously ill participants of ultra-endurance events in remote environments.

Authors:  Martin D Hoffman; Ian R Rogers; Jeremy Joslin; Chad A Asplund; William O Roberts; Benjamin D Levine
Journal:  Sports Med       Date:  2015-02       Impact factor: 11.136

2.  Collapsed athlete - atraumatic.

Authors:  Dennis Y Wen
Journal:  Curr Rev Musculoskelet Med       Date:  2014-12

3.  Heat-related illness in sports and exercise.

Authors:  Andrew W Nichols
Journal:  Curr Rev Musculoskelet Med       Date:  2014-12

4.  Medical services at ultra-endurance foot races in remote environments: medical issues and consensus guidelines.

Authors:  Martin D Hoffman; Andy Pasternak; Ian R Rogers; Morteza Khodaee; John C Hill; David A Townes; Bernd Volker Scheer; Brian J Krabak; Patrick Basset; Grant S Lipman
Journal:  Sports Med       Date:  2014-08       Impact factor: 11.136

Review 5.  Blood pressure regulation X: what happens when the muscle pump is lost? Post-exercise hypotension and syncope.

Authors:  John R Halliwill; Dylan C Sieck; Steven A Romero; Tahisha M Buck; Matthew R Ely
Journal:  Eur J Appl Physiol       Date:  2013-11-07       Impact factor: 3.078

Review 6.  Pathophysiology of Noncardiac Syncope in Athletes.

Authors:  Georgios A Christou; Konstantinos A Christou; Dimitrios N Kiortsis
Journal:  Sports Med       Date:  2018-07       Impact factor: 11.136

Review 7.  Crawling to the finish line: why do endurance runners collapse? Implications for understanding of mechanisms underlying pacing and fatigue.

Authors:  Alan St Clair Gibson; Jos J De Koning; Kevin G Thompson; William O Roberts; Dominic Micklewright; John Raglin; Carl Foster
Journal:  Sports Med       Date:  2013-06       Impact factor: 11.136

8.  Clinical Impact of Speed Variability to Identify Ultramarathon Runners at Risk for Acute Kidney Injury.

Authors:  Sen-Kuang Hou; Yu-Hui Chiu; Yi-Fang Tsai; Ling-Chen Tai; Peter C Hou; Chorng-Kuang How; Chen-Chang Yang; Wei-Fong Kao
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

Review 9.  Are we being drowned in hydration advice? Thirsty for more?

Authors:  James David Cotter; Simon N Thornton; Jason Kw Lee; Paul B Laursen
Journal:  Extrem Physiol Med       Date:  2014-10-29

Review 10.  Physiopathological, Epidemiological, Clinical and Therapeutic Aspects of Exercise-Associated Hyponatremia.

Authors:  Caterina Urso; Salvatore Brucculeri; Gregorio Caimi
Journal:  J Clin Med       Date:  2014-11-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.